11.1 Information on toxicological effects
Acute toxicity
Oral: No data available
Inhalation: No data available
Dermal: No data available
Skin corrosion/irritation
Remarks: No data available
Serious eye damage/eye irritation
Remarks: No data available
Respiratory or skin sensitization
Classified based on available data. For more details, see section 2
Germ cell mutagenicity
Classified based on available data. For more details, see section 2
Carcinogenicity
Some steroids show carcinogenic and teratogenic activity. This product is or contains a component that has been reported to be possibly carcinogenic based on its IARC, ACGIH,
NTP, or EPA classification.
Limited evidence of carcinogenicity in animal studies
Reproductive toxicity
Some steroids show carcinogenic and teratogenic activity.
Suspected human reproductive toxicant
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Endocrine disrupting properties
Product:
Assessment : The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Breast enlargement in males and female children., Some steroids show carcinogenic and teratogenic activity., Nausea, Headache, Vomiting